NeoGenomics, Inc. Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31)
NeoGenomics, Inc. (NEO) had Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) of $2.00 million as of 2014-06-30, per its 10-Q filed 2014-07-29.
Discontinued › Notes
us-gaap:LineOfCreditFacilityAmountOutstanding · last filed 2014-07-29
- 2014-06-30: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $2.00M.
- 2014-03-31: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $4.90M.
- 2013-12-31: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $4.30M.
- 2013-09-30: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $2.70M.
| Period end | Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) |
|---|---|
| 2014-06-30 | $2.00M 10-Q · filed 2014-07-29 |
| 2014-03-31 | $4.90M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $4.30M 10-K · filed 2014-02-24 |
| 2013-09-30 | $2.70M 10-Q · filed 2013-10-30 |
| 2013-06-30 | $3.20M 10-Q · filed 2013-08-02 |
| 2013-03-31 | $4.20M 10-Q · filed 2013-05-13 |
| 2012-12-31 | $8.50M 10-K · filed 2013-02-21 |
| 2012-09-30 | $8.00M 10-Q · filed 2012-11-05 |
| 2012-06-30 | $6.40M 10-Q/A · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |